Robert Sgrignoli, DO
Hematology & Oncology · Tripler Army Medical Center, HINPI 1083102420
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $193 and has fallen 82.5% since, to $34 in 2025. That places this record below the midpoint for hematology & oncology clinicians in HI, where the typical reported total is $1,482.
Across 17 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$42
- Karyopharm Therapeutics Inc.$39
- AstraZeneca$34
- Amgen$31
- GSK$27
- Gilead$26
- plus $148 from 7 others
What the payments were for
- Food & beverage$348100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 2 | $42 |
| Karyopharm Therapeutics Inc. | 2 | $39 |
| AstraZeneca | 2 | $34 |
| Amgen | 2 | $31 |
| GSK | 1 | $27 |
| Gilead | 1 | $26 |
| Morphosys, US Inc. | 1 | $25 |
| Seagen Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Bayer | 1 | $22 |
| Eisai Inc. | 1 | $20 |
| Progenics Pharmaceuticals, Inc. | 1 | $19 |
| Servier Pharmaceuticals LLC | 1 | $17 |
How this compares
$348 in reported general payments places this provider in the 30th percentile of 42 hematology & oncology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 16 | $54 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Tripler Army Medical Center
- James NguyenTripler Army Medical Center$247
- Tamie KernsHonolulu$48K
- David TamuraHonolulu$31K
- Melvin PalalayHonolulu$20K
- Ryon NakasoneHonolulu$20K
- Arnold YeeHonolulu$17K
- Jared AcobaHonolulu$15K
- Swaty AroraHonolulu$15K
- Ramin AltahaWailuku$13K
- William LouiHonolulu$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.